Tsuyoshi Nagase

1.4k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Tsuyoshi Nagase is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tsuyoshi Nagase has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tsuyoshi Nagase's work include Glycosylation and Glycoproteins Research (6 papers), Mast cells and histamine (5 papers) and Receptor Mechanisms and Signaling (5 papers). Tsuyoshi Nagase is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Mast cells and histamine (5 papers) and Receptor Mechanisms and Signaling (5 papers). Tsuyoshi Nagase collaborates with scholars based in Japan, United States and Norway. Tsuyoshi Nagase's co-authors include Seiji Shinkai, Itaru Hamachi, Toshiaki Mase, Toshihiko Saeki, Satoshi Ozaki, Tatsuki Fukami, M. Ihara, Takahiro Fukuroda, Kazuhito Noguchi and Kiyofumi Ishikawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Communications.

In The Last Decade

Tsuyoshi Nagase

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

1994 517 citations Tsuyoshi Nagase et al. profile →

Peers

Countries citing papers authored by Tsuyoshi Nagase

Since Specialization

Citations

This map shows the geographic impact of Tsuyoshi Nagase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuyoshi Nagase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuyoshi Nagase more than expected).

Fields of papers citing papers by Tsuyoshi Nagase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuyoshi Nagase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuyoshi Nagase. The network helps show where Tsuyoshi Nagase may publish in the future.

Co-authorship network of co-authors of Tsuyoshi Nagase

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuyoshi Nagase. A scholar is included among the top collaborators of Tsuyoshi Nagase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuyoshi Nagase. Tsuyoshi Nagase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6 2010 ·European Journal of Pharmacology ·(unknown), Akira Nagumo, Yasuhisa Miyamoto, Hidefumi Kitazawa, (unknown), Ryo Yoshimoto, Katsumi Aragane, (unknown), Tomoyuki Ohe, Toshiyuki Takahashi, Tsuyoshi Nagase, Nagaaki Sato, Shigeru Tokita	18
2	5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a Potent Inhibitor for Mammalian Elongase of Long-Chain Fatty Acids Family 6: Examination of Its Potential Utility as a Pharmacological Tool 2009 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Hidefumi Kitazawa, Yasuhisa Miyamoto, (unknown), Akira Nagumo, Ryo Yoshimoto, Katsumi Aragane, (unknown), Tomoyuki Ohe, Toshiyuki Takahashi, Tsuyoshi Nagase, Nagaaki Sato, Shigeru Tokita	13
3	Synthesis and evaluation of a novel 2-azabicyclo[2.2.2]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors 2009 ·Bioorganic & Medicinal Chemistry ·(unknown), Tsuyoshi Nagase, Toshiyuki Takahashi, Akira Nagumo, (unknown), Yasuhisa Miyamoto, Hidefumi Kitazawa, (unknown), Ryo Yoshimoto, Katsumi Aragane, Shigeru Tokita, Nagaaki Sato	4
4	Hemodynamic and Cardiac Neurotransmitter-releasing Effects in Conscious Dogs of Attention- and Wake-promoting Agents: A Comparison of d-Amphetamine, Atomoxetine, Modafinil, and a Novel Quinazolinone H3 Inverse Agonist 2009 ·Journal of Cardiovascular Pharmacology ·Joseph J. Lynch, Christopher P. Regan, Gary L. Stump, Pamela L. Tannenbaum, Joanne Stevens, Ashleigh Bone, (unknown), (unknown), (unknown), Norihiro Takenaga, Shigeru Tokita, Tsuyoshi Nagase, Nagaaki Sato, John J. Renger	8
5	Development of a selective and potent radioactive ligand for histamine H3 receptors: A compound potentially useful for receptor occupancy studies 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yuko Mitobe, Sayaka Ito, Takashi Mizutani, Tsuyoshi Nagase, Nagaaki Sato, Shigeru Tokita	71
6	Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor 2009 ·Bioorganic & Medicinal Chemistry ·Makoto Ando, Nagaaki Sato, Tsuyoshi Nagase, (unknown), Shiho Ishikawa, (unknown), Norikazu Ohtake, Junko Itô, (unknown), Yuko Mitobe, Hisashi Iwaasa, Akira Gomori, Hiroko Matsushita, (unknown), (unknown), Sachiko Tanaka, Tomoyuki Ohe, Akane Ishihara, Akio Kanatani, Takehiro Fukami	16
7	Identification and Characterization of a Selective Radioligand for ELOVL6 2009 ·The Journal of Biochemistry ·(unknown), Hidekazu Takahashi, Hidefumi Kitazawa, Yasuhisa Miyamoto, Akira Nagumo, (unknown), Dennis R. Dean, Tsuyoshi Nagase, Nagaaki Sato, Shigeru Tokita	2
8	Synthesis and Evaluation of a Novel Indoledione Class of Long Chain Fatty Acid Elongase 6 (ELOVL6) Inhibitors 2009 ·Journal of Medicinal Chemistry ·Toshiyuki Takahashi, Tsuyoshi Nagase, (unknown), Akira Nagumo, (unknown), Yasuhisa Miyamoto, Hidefumi Kitazawa, (unknown), Ryo Yoshimoto, Katsumi Aragane, Shigeru Tokita, Nagaaki Sato	34
9	Synthesis and Biological Evaluation of a Novel 3-Sulfonyl-8-azabicyclo[3.2.1]octane Class of Long Chain Fatty Acid Elongase 6 (ELOVL6) Inhibitors 2009 ·Journal of Medicinal Chemistry ·Tsuyoshi Nagase, Toshiyuki Takahashi, (unknown), Akira Nagumo, (unknown), Yasuhisa Miyamoto, Hidefumi Kitazawa, (unknown), Ryo Yoshimoto, Katsumi Aragane, Shigeru Tokita, Nagaaki Sato	11
10	Synthesis, structure–activity relationships, and biological profiles of a dihydrobenzoxathiin class of histamine H3 receptor inverse agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Toshiyuki Takahashi, Tsuyoshi Nagase, Takashi Mizutani, Sayaka Ito, Yuko Mitobe, Yasuhisa Miyamoto, (unknown), Ryo Yoshimoto, Takeshi Tanaka, Norihiro Takenaga, Shigeru Tokita, Nagaaki Sato	7
11	Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Takashi Mizutani, Tsuyoshi Nagase, Sayaka Ito, Yasuhisa Miyamoto, Takeshi Tanaka, Norihiro Takenaga, Shigeru Tokita, Nagaaki Sato	29
12	Construction of Artificial Signal Transducers on a Lectin Surface by Post‐Photoaffinity‐Labeling Modification for Fluorescent Saccharide Biosensors 2003 ·Chemistry - A European Journal ·Tsuyoshi Nagase, Eiji Nakata, Seiji Shinkai, Itaru Hamachi	49
13	Coupling a Natural Receptor Protein with an Artificial Receptor to Afford a Semisynthetic Fluorescent Biosensor 2003 ·Journal of the American Chemical Society ·Eiji Nakata, Tsuyoshi Nagase, Seiji Shinkai, Itaru Hamachi	56
14	Post-photoaffinity labeling modification using aldehyde chemistry to produce a fluorescent lectin toward saccharide-biosensors 2001 ·Chemical Communications ·Tsuyoshi Nagase, Seiji Shinkai, Itaru Hamachi	34
15	Inhibition of β-Lactamases by 6,6-Bis(hydroxylmethyl)penicillanate 2001 ·Bioorganic Chemistry ·Tsuyoshi Nagase, Dasantila Golemi, Akihiro Ishiwata, Shahriar Mobashery	3
16	6-(Hydroxyalkyl)penicillanates as Probes for Mechanisms of .BETA.-Lactamases. 2000 ·The Journal of Antibiotics ·Dasantila Golemi, Laurent Maveyraud, Akihiro Ishiwata, (unknown), Kazuyuki Miyashita, Tsuyoshi Nagase, Irina Massova, Lionel Mourey, Jean‐Pierre Samama, Shahriar Mobashery	16
17	Stereoselective Reduction of α-Bromopenicillanates by Tributylphosphine 2000 ·Organic Letters ·Akihiro Ishiwata, Lakshmi P. Kotra, Kazuyuki Miyashita, Tsuyoshi Nagase, Shahriar Mobashery	6
18	Design and Synthesis of Sugar‐Responsive Semiartificial Myoglobin Triggered by Modulation of Apoprotein–Cofactor Interactions 1997 ·Chemistry - A European Journal ·Itaru Hamachi, (unknown), Tsuyoshi Nagase, Seiji Shinkai	20
19	Pharmacological effects of the novel dopamine uptake inhibitor 1-(2-(bis(4-fluorophenyl)-methoxy)ethyl)-4-(3-phenylpropyl) piperazine dihydrochloride (I-893) on the central nervous system. 1991 ·Folia Pharmacologica Japonica ·Tsuyoshi Nagase, (unknown), (unknown), Ken Sakai, Miki Yamane, (unknown), (unknown)	1
20	Effects of 1-(2-(bis(fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl) piperazine dihydrochloride(I-893) on turnover of dopamine and norepinephrine in the brain. 1987 ·Folia Pharmacologica Japonica ·Tsuyoshi Nagase, (unknown), Shuji Takaori	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact